RAD52 is a recombinase, binds RAD51 and is a component of the homologous recombination DNA repair pathway.
| Inventor | Institute |
|---|---|
| Stephen West | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| Cat. #: | 151325 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics |
| Application: | IP ; WB ; FACS ; IP ; WB |
| Target: | Rad52 |
| Reactivity: | Human |
| Clone: | FBE3 |
| Host: | Rabbit |
| Class: | Polyclonal |
| Product description: | RAD52 is a recombinase, binds RAD51 and is a component of the homologous recombination DNA repair pathway. |
|---|---|
| Conjugation: | Unconjugated |
| Immunogen: | Purified full length recombinant His-tagged Rad52. |
| Target background: | RAD52 is a recombinase, binds RAD51 and is a component of the homologous recombination DNA repair pathway. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | Whole serum |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Ahn et al. 2015. Nucleic Acids Res. 43(13):6321-33. PMID: 26068472. Tang et al. 2014. PLoS One. 9(11):e111584. PMID: 25365323. Muylaert et al. 2010. J Biol Chem. 285(18):13761-8. PMID: 20215648. Masson et al. 1999. EMBO J. 18(22):6552-60. PMID: 10562567. The meiosis-specific recombinase hDmc1 forms ring structures and interacts with hRad51. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.